Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions

British Journal of Cancer

Volumn 59, Issue 3, 1989, Pages 341-346

  Marshall, R S ^a   Paterson, M C ^b   Rauth, A M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DICOUMAROL; MITOMYCIN C; PORFIROMYCIN;

CELL CULTURE; CELL LINE; DRUG RESISTANCE; FIBROBLAST; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL;

BIOTRANSFORMATION; CELL SURVIVAL; CELLS, CULTURED; DICUMAROL; DRUG RESISTANCE; FIBROBLASTS; HUMAN; MITOMYCIN; MITOMYCINS; OXYGEN; PORFIROMYCIN; SKIN; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024557260     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1989.67     Document Type: Article

References (38)

1. BENSON, A.M., HUNKELER, M.J. & TALALAY, P. (1980). Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl Acad. Sci. USA, 77, 5216.
2. CHAKRABARTY, S., DANELS, Y.J., LONG, B.H., WILLSON, J.K.V. & BRATTAIN, M.G. (1986). Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY 25282. Cancer Res., 46, 3456.
3. CONOVER, T.E. & ERNSTER, L. (1962). DT Diaphorase II relation to respiratory chain of intact mitochondria. Biochim. Biophys. Acta, 58, 189.
4. DORR, R.T., LIDDIL, J.D., TRENT, J.M. & DALTON, W.S. (1987). Mitomycin C resistant LI210 leukemia cells: association with pleiotropic drug resistance. Biochem. Pharmacol., 36, 3115.
5. ERNSTER, L., DANIELSON, L. & LJUNGGREN, M. (1962). DT Diaphorase I purification from the soluble fraction of rat-liver cytoplasm, and properties. Biochim. Biophyss. Acta, 58, 171.
6. FRACASSO, P.M. & SARTORELLI, A.C. (1986). Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells. Cancer Res., 46, 3939.
7. GEARD, C.R. & GEORGSSON, M.A. (1986). Glutathione levels and cytotoxicity of a thiol activated alkylating agent in human and mouse cells. Int. J. Radiat. Oncol. Biol. Phys., 12, 1179.
8. GUPTA, V. & CONSTANZI, J.J. (1987). Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich Ascites cells. Cancer Res., 47, 2407.
9. IYANAGI, T. & YAMAZAKI, I. (1970). One-electron-transfer reactions in biochemical systems. V: difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim. Biophys. Acta., 216, 282.
10. IYER, V.N. & SZYBALSKI, W. (1963). A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc. Natl Acad. Sci. USA, 50, 355.
11. KARTNER, N., RIORDAN, J R. & LING, V. (1983). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285.
12. KENNEDY, K.A., ROCKWELL, S. & SARTORELLI, A.C. (1980). Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic cells. Cancer Res., 40, 2356.
13. KENNEDY, K.A., SLIGAR, S.G., POLOMSKI, L. & SARTORELLI, A.C. (1982). Metabolic activation of mitomycin C by liver microsomes and nuclei. Biochem. Pharmacol., 31, 2011.
14. KEYES, S R., FRACASSO, P.M., HEIMBROOK, D C., ROCKWELL, S., SLIGAR, S.G. & SARTORELLI, A.C. (1984). Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44, 5628.
15. KEYES, S.R., ROCKWELL, S. & SARTORELLI, A.C. (1985a). Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res., 45, 213.
16. KEYES, S.R., ROCKWELL, S. & SARTORELLI, A.C. (1985b). Porfiro-mycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res., 45, 3642.
17. KEYES, S R., ROCKWELL, S. & SARTORELLI, A.C. (1986). Mechanistic studies on dicumarol-enhanced toxicity of mitomycin C and porfiromycin to hypoxic EMT6 tumour cells. Proc. Am. Assoc. Cancer Res., 27, 233.
18. KEYES, S.R., ROCKWELL, S. & SARTORELLI, A.C. (1987). Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells. Cancer Res., 47, 5654.
19. LONG, B.H., WILLSON, J.K.V., BRATTAIN, D.E., MUSIAL, S. & BRATTAIN, M.G. (1984). Effects of mitomycin C on human colon carcinoma cells. J. Natl Cancer Inst., 73, 787.
20. LUDWIG, C. (1984). Drug resistance of hypoxic tumour cells in vitro. Cancer Treat. Rev., 11, 173.
21. MARSHALL, R.S., KOCH, C.J. & RAUTH, A.M. (1986). Meaasurement of low levels of oxygen and their effect on respiration in cell suspensions maintained in an open system. Radiat. Res., 108, 91.
22. MARSHALL, R.S., PATERSON, M.C. & RAUTH, A.M. (1989). Aerobic resistance of a human cell strain to mitomycin C and porfiromycin is lost under hypoxic exposure conditions. Biochem. Pharmacol., in the press.
23. MARSHALL, R.S. & RAUTH, A.M. (1986). Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant. Cancer Res., 46, 2709.
24. MEYN, R.E., JENKINS, S.F. & THOMPSON, L.H. (1982). Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster ovary cells. Cancer Res., 42, 3106.
25. PAN, S.S., ANDREWS, P.A. & GLOVER, C.J. (1984). Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P450 reductase and xanthine oxidase. J. Binl. Client. 259, 959.
26. PATERSON, M.C., MIDDLESTADT, M.V., WEINFELD, M., MIRZAYANS, R. & GENTNER, N.E. (1986). Human cancer-prone disorders, abnormal carcinogen response, and defective DNA metabolism. In Radiation Carcinogenesis and DNA Alterations, Burns, F.J., Upton, A.C. & Silini, G. (eds) p. 471. Plenum Press: New York.
27. PINTO, A.L. & LIPPARD, S.J. (1985). Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim. Biophys. Acta, 780, 167.
28. PLOOY, A.C.M., VAN DIJK, M., BERENDS, F. & LOHMAN, P.H.M. (1985). Formation and repair of DNA interstrand crosslinks in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with ds-diammine-dichloroplatinum(II). Cancer Res., 45, 4178.
29. RAHMOUNI, A. & LENG, M. (1987). Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand cross-links. Biochemistry, 26, 7229.
30. ROCKWELL, S. (1983). Effects of mitomycin C alone and in combination with x-rays on EMT6 mouse mammary tumours in vivo. J. Natl Cancer Inst., 71, 765.
31. ROCKWELL, S. (1986). Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumour cells in vitro. Int. J. Cancer, 38, 229.
32. ROCKWELL, S. & SARTORELLI, A.C. (1989). Mitomycin C and radiation. In Interactions Between Antitumor Drugs and Radiation, Hill, B. & Bellamy, A. (eds). CRC Press: Boca Raton, FL.
33. SHRIEVE, D.C. & HARRIS, J.W. (1986). Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation. Int. J. Radiat. Oncol. Biol. Phys., 12, 1171.
34. TAYLOR, C.W., BRATTAIN, M.G. & YEOMAN, L.C. (1985). Occurrence of cytosolic protein and phosphoprotein changes in human colon tumor cells with the development of resistance to mitomycin C. Cancer Res., 45, 4422.
35. THOMPSON, L.H., RUBIN, J.S., CLEAVER, J.E., WHITMORE, G.F. & BROOKMAN, K. (1980). A screening method for isolating DNA repair-deficient mutants of CHO cells. Somatic Cell Genet., 6, 391.
36. THOR, H., SMITH, M.T., HARTZELL, P., BELLOMO, G., JEWELL, S.A. & ORRENIUS, S. (1982). The metabolism of menadione (2-methyl-1, 4-naphthoquinone) by isolated hepatocytes. J. Biol. Chem., 257, 12419.
37. WILLSON, J.K., LONG, B.H., CHAKRABARTY, S., BRATTAIN, D.E. & BRATTAIN, M.G. (1985). Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells. Cancer Res., 45, 5281.
38. WILLSON, J.K.V., LONG, B.H., MARKS, M E., BRATTAIN, D.E., WILEY, J.E. & BRATTAIN, M.G. (1984). Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations. Cancer Res., 44, 5880.